1802552-04-0: Pemetrexed EP Impurity B

Pemetrexed EP Impurity B (CAS No: 1802552-04-0) is a methotrexate derivative, it is first-line therapy for the treatment of malignant mesothelioma.

Additional information

Catalogue No.

VE006975

CAS No.

1802552-04-0

Molecular Formula

C40H40N10O13

Molecular Weight

868.8 g/mol

IUPAC Name

(2S)-2-(4-(2-((R)-2-amino-4, 6-dioxo-4, 5, 6, 7-tetrahydro-1H-pyrrolo[2, 3-d]pyrimidin-5-yl)-2-(2-amino-5-(4-(((S)-1, 3-dicarboxypropyl)carbamoyl)phenethyl)-4-oxo-4, 7-dihydro-1H-pyrrolo[2, 3-d]pyrimidin-6-yl)ethyl)benzamido)pentanedioic acid

Synonyms

Pemetrexed BP Impurity B / Pemetrexed (5R)-Dimer

References

Sci-Hub, Mutational Profiling of Malignant Mesothelioma Revealed Potential Therapeutic Targets in EGFR and NRAS, 10.1016/j.tranon.2018.01.005. (2018). Retrieved November 29, 2021, from Hkvisa.net website: https://sci-hub.hkvisa.net/10.1016/j.tranon.2018.01.005 ?

Status

In-stock